Loading...

REGN REGENERON PHARMACEUTICALS INC Management Changes 8-K Filing

RGNR

RGN

REGENERON PHARMACEUTICALS INC

(REGN)

2023 8-K

Show Summary

Summary

Financial Statements

Financial Results

Financial Update

Q3 Earnings Report

Q3 2024 Preview

Earnings Reports

Financial Results

Shareholder Vote Results

Financial Results

Financial Results Announcement

Management Appointments

Corporate Update at Healthc...

Financial Results Announcement

Financial Results

Earnings Reports

Amendment to Bylaws and Sha...

Financial Results Announcement

Management Changes

Financial Results for Q1 2023

External Links:

Regeneron Pharmaceuticals, Inc. announced that P. Roy Vagelos, Chair of the board of directors, will not stand for re-election at the 2023 Annual Meeting of Shareholders and Leonard S. Schleifer and George D. Yancopoulos will be elected as Co-Chairs of the Board.

AI Assistant

REGENERON PHARMACEUTICALS INC

2023

8 K

Find Answers

Ask about any part of the document to get insights, explanations, or key details.